Loading...
Please wait, while we are loading the content...
Pharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals
| Content Provider | Semantic Scholar |
|---|---|
| Author | Jacobzone, Stéphane |
| Copyright Year | 2000 |
| Abstract | Regulation of the pharmaceutical sector needs to reconcile private and social objectives. Public intervention pursues multiple goals which relate to both health and industry policy. Many OECD Governments are also heavily involved as buyers of pharmaceuticals in publicly-financed health care systems. This paper describes recent trends in pharmaceutical expenditure and financing in a first chapter. A second chapter discusses the economics of pharmaceutical markets. A third chapter provides a review of national policies and their attempts to balance public and private objectives. Pharmaceutical expenditure has been rising steadily as a share of GDP since 1970. However, total health expenditure has also risen. As a result, pharmaceutical expenditure has, on average, maintained its share of total health expenditure in the OECD, close to 15 %. Across countries, pharmaceutical expenditure per capita depends on relative incomes but is also influenced by institutional features. The pharmaceutical ... La regulation du secteur pharmaceutique doit reconcilier des objectifs sociaux et prives. L'intervention publique poursuit des objectifs multiples, relatifs tant a la politique de sante qu'a la politique industrielle. De nombreux gouvernements de l'OCDE sont egalement profondement engages en tant qu'acheteurs de medicaments dans des systemes de sante finances sur fonds publics. Dans un premier chapitre, cette etude decrit des tendances recentes des depenses pharmaceutiques et du financement. Un second chapitre discute l'economie des marches du medicament. Un troisieme chapitre offre une revue des politiques nationales et de leurs efforts pour equilibrer les objectifs publics et prives. Les depenses pharmaceutiques ont vu leur part du PIB s'accroitre constamment depuis 1970. Cependant, la part des depenses de sante s'est aussi accrue. Il en resulte que les depenses de medicament ont dans l'ensemble maintenu leur part au sein des depenses de sante, proche de 15 %. Les depenses de ... |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://www.oecd-ilibrary.org/docserver/323807375536.pdf?accname=guest&checksum=2C69D91B7AAB26B2F734B2D05D10AB08&expires=1544555077&id=id |
| Alternate Webpage(s) | https://www.oecd-ilibrary.org/docserver/323807375536.pdf?accname=guest&checksum=05912E5130AAA9C5C6DB70FA6C5893A7&expires=1574416407&id=id |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
